Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Coeptis Therapeutics Holdings (COEPW) Interest Expenses (2022 - 2025)

Historic Interest Expenses for Coeptis Therapeutics Holdings (COEPW) over the last 4 years, with Q3 2025 value amounting to $62610.0.

  • Coeptis Therapeutics Holdings' Interest Expenses rose 2294.31% to $62610.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $280518.0, marking a year-over-year decrease of 1533.3%. This contributed to the annual value of $396116.0 for FY2024, which is 26784.7% up from last year.
  • As of Q3 2025, Coeptis Therapeutics Holdings' Interest Expenses stood at $62610.0, which was up 2294.31% from $67788.0 recorded in Q2 2025.
  • In the past 5 years, Coeptis Therapeutics Holdings' Interest Expenses ranged from a high of $200505.0 in Q1 2024 and a low of $13832.0 during Q4 2023
  • For the 4-year period, Coeptis Therapeutics Holdings' Interest Expenses averaged around $67828.6, with its median value being $62610.0 (2025).
  • Per our database at Business Quant, Coeptis Therapeutics Holdings' Interest Expenses plummeted by 8980.47% in 2023 and then surged by 53820.54% in 2024.
  • Quarter analysis of 4 years shows Coeptis Therapeutics Holdings' Interest Expenses stood at $135671.0 in 2022, then tumbled by 89.8% to $13832.0 in 2023, then skyrocketed by 468.46% to $78629.0 in 2024, then decreased by 20.37% to $62610.0 in 2025.
  • Its last three reported values are $62610.0 in Q3 2025, $67788.0 for Q2 2025, and $71491.0 during Q1 2025.